Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Statin use and risk of liver cancer: Evidence from two population-based studies.

Tran KT, McMenamin ÚC, Coleman HG, Cardwell CR, Murchie P, Iversen L, Lee AJ, Thrift AP.

Int J Cancer. 2019 May 21. doi: 10.1002/ijc.32426. [Epub ahead of print]

PMID:
31112291
2.

Coffee consumption by type and risk of digestive cancer: a large prospective cohort study.

Tran KT, Coleman HG, McMenamin ÚC, Cardwell CR.

Br J Cancer. 2019 May;120(11):1059-1066. doi: 10.1038/s41416-019-0465-y. Epub 2019 May 1.

PMID:
31040384
3.

Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study.

McMenamin ÚC, Trainor J, Coleman HG, McManus DT, McQuaid S, Bingham V, James J, Salto-Tellez M, Johnston BT, Turkington RC.

Oncotarget. 2018 Oct 19;9(82):35300-35312. doi: 10.18632/oncotarget.26236. eCollection 2018 Oct 19.

4.

Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study.

McCain S, Trainor J, McManus DT, McMenamin ÚC, McQuaid S, Bingham V, James JA, Salto-Tellez M, Turkington RC, Coleman HG.

Oncotarget. 2018 Sep 28;9(76):34347-34356. doi: 10.18632/oncotarget.26151. eCollection 2018 Sep 28.

5.

Physical activity, sedentary behaviour and risk of oesophago-gastric cancer: A prospective cohort study within UK Biobank.

Kunzmann AT, Mallon KP, Hunter RF, Cardwell CR, McMenamin ÚC, Spence AD, Coleman HG.

United European Gastroenterol J. 2018 Oct;6(8):1144-1154. doi: 10.1177/2050640618783558. Epub 2018 Jun 7.

6.

Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors.

Kunzmann AT, Cañadas Garre M, Thrift AP, McMenamin ÚC, Johnston BT, Cardwell CR, Anderson LA, Spence AD, Lagergren J, Xie SH, Smyth LJ, McKnight AJ, Coleman HG.

Gastroenterology. 2019 Jan;156(1):43-45. doi: 10.1053/j.gastro.2018.09.038. Epub 2018 Sep 19.

PMID:
30243622
7.

Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies.

Tran KT, McMenamin ÚC, Hicks B, Murchie P, Thrift AP, Coleman HG, Iversen L, Johnston BT, Lee AJ, Cardwell CR.

Aliment Pharmacol Ther. 2018 Jul;48(1):55-64. doi: 10.1111/apt.14796. Epub 2018 May 9.

PMID:
29741272
8.

Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma.

Kunzmann AT, Thrift AP, Cardwell CR, Lagergren J, Xie S, Johnston BT, Anderson LA, Busby J, McMenamin ÚC, Spence AD, Coleman HG.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1229-1236.e4. doi: 10.1016/j.cgh.2018.03.014. Epub 2018 Mar 17.

PMID:
29559360
9.

Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population-based databases.

Spence AD, Busby J, Murchie P, Kunzmann AT, McMenamin ÚC, Coleman HG, Johnston BT, O'Rorke MA, Murray LJ, Iversen L, Lee AJ, Cardwell CR.

Int J Cancer. 2018 Jul 1;143(1):22-31. doi: 10.1002/ijc.31293. Epub 2018 Mar 8.

PMID:
29396851
10.

Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review.

Spence AD, Cardwell CR, McMenamin ÚC, Hicks BM, Johnston BT, Murray LJ, Coleman HG.

BMC Gastroenterol. 2017 Dec 11;17(1):157. doi: 10.1186/s12876-017-0708-4. Review.

11.

Do smoking and alcohol behaviours influence GI cancer survival?

McMenamin ÚC, McCain S, Kunzmann AT.

Best Pract Res Clin Gastroenterol. 2017 Oct;31(5):569-577. doi: 10.1016/j.bpg.2017.09.015. Epub 2017 Sep 23. Review.

PMID:
29195677
12.

Blood biomarkers for early diagnosis of oesophageal cancer: a systematic review.

Kunzmann AT, McMenamin ÚC, Spence AD, Gray RT, Murray LJ, Turkington RC, Coleman HG.

Eur J Gastroenterol Hepatol. 2018 Mar;30(3):263-273. doi: 10.1097/MEG.0000000000001029. Review.

PMID:
29189391
13.

Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment.

Treanor CJ, McMenamin UC, O'Neill RF, Cardwell CR, Clarke MJ, Cantwell M, Donnelly M.

Cochrane Database Syst Rev. 2016 Aug 16;(8):CD011325. doi: 10.1002/14651858.CD011325.pub2. Review.

PMID:
27529826
14.

PTGS2 (Cyclooxygenase-2) expression and survival among colorectal cancer patients: a systematic review.

Kunzmann AT, Murray LJ, Cardwell CR, McShane CM, McMenamin UC, Cantwell MM.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1490-7. doi: 10.1158/1055-9965.EPI-13-0263. Epub 2013 Jun 27. Review.

Supplemental Content

Loading ...
Support Center